Current and emerging first-line systemic therapies in clear cell renal cell carcinoma

Clin Adv Hematol Oncol. 2018 Feb;16(2):115-117.

Author

Affiliation

¹ Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.

PMID: 29741511

No abstract available

Publication types

Interview

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Renal Cell / diagnosis
Carcinoma, Renal Cell / drug therapy*
Carcinoma, Renal Cell / mortality
Clinical Decision-Making
Clinical Trials as Topic
Disease Management
Humans
Kidney Neoplasms / diagnosis
Kidney Neoplasms / drug therapy*
Kidney Neoplasms / mortality
Molecular Targeted Therapy / adverse effects
Molecular Targeted Therapy / methods
Mortality
Patient Selection
Treatment Outcome